Roswell Biotechnologies To Present At The Biotech Showcase 2018 Conference
SAN DIEGO, Dec. 22, 2017 /PRNewswire/ -- Roswell Biotechnologies, a molecular electronics company transforming DNA sequencing, today announced that it will be presenting at the Biotech Showcase 2018 Conference being held at the Hilton San Francisco Union Square hotel. Co-founders Paul Mola and Barry Merriman will present an overview of the company and technology.
Details of Roswell's presentation are as follows:
|
Wednesday, January 10th, 2018 |
|
9:45 a.m. PST |
|
Franciscan D |
About Biotech Showcase 2018
Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year.
About Roswell Biotechnologies
Roswell Biotechnologies is a privately-held company developing molecular electronics for DNA sequencing and related biosensor applications. Roswell maintains its headquarters in San Diego, California. To learn more please visit www.roswellbiotech.com.
Contact: Amy Conrad Email: [email protected] Phone: (858) 366-3243
View original content:http://www.prnewswire.com/news-releases/roswell-biotechnologies-to-present-at-the-biotech-showcase-2018-conference-300574802.html
SOURCE Roswell Biotechnologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- International Paper Continues Strategic Transformation with North America Packaging Network Optimization
- Tri Pointe Homes Celebrates Grand Opening of Auburn at Cordovan in Firestone with New Home Designs, Community Amenities, and Grand Opening Festivities
- Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Merriman Curhan FordSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share